Stockscreener 앱 받기
24.54
2.62%
0.645
전일 마감가:
$23.89
열려 있는:
$23.92
하루 거래량:
1.38M
Relative Volume:
0.71
시가총액:
$4.06B
수익:
-
순이익/손실:
$-451.71M
주가수익비율:
-7.6052
EPS:
-3.2261
순현금흐름:
$-462.19M
1주 성능:
+3.26%
1개월 성능:
+20.59%
6개월 성능:
+36.19%
1년 성능:
+165.31%
1일 변동 폭
$23.70
$24.87
1주일 범위
$21.71
$24.87
52주 변동 폭
$8.88
$25.00
다인 테라 Stock (DYN) Company Profile
명칭
Dyne Therapeutics Inc
전화
(781) 786-8230
주소
1560 TRAPELO ROAD, WALTHAM
Compare DYN vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DYN
Dyne Therapeutics Inc
|
24.55 | 3.95B | 0 | -451.71M | -462.19M | -3.2261 |
VRTX
Vertex Pharmaceuticals Inc
|
480.00 | 120.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
665.67 | 68.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.09 | 57.84B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.74 | 40.13B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
275.34 | 35.88B | 4.29B | 577.22M | 641.34M | 4.2086 |
다인 테라 Stock (DYN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-10 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-10-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-25 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-06-24 | 개시 | Bernstein | Mkt Perform |
| 2025-06-11 | 재개 | Raymond James | Outperform |
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-29 | 개시 | Evercore ISI | Outperform |
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-13 | 개시 | Robert W. Baird | Outperform |
| 2024-11-26 | 개시 | RBC Capital Mkts | Outperform |
| 2024-10-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-21 | 재확인 | Chardan Capital Markets | Buy |
| 2024-04-30 | 개시 | Morgan Stanley | Overweight |
| 2024-02-20 | 개시 | H.C. Wainwright | Buy |
| 2023-02-27 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-02-15 | 개시 | Oppenheimer | Outperform |
| 2023-01-26 | 개시 | Guggenheim | Buy |
| 2022-07-20 | 개시 | Chardan Capital Markets | Buy |
| 2022-07-12 | 개시 | Raymond James | Outperform |
| 2020-10-12 | 개시 | JP Morgan | Overweight |
| 2020-10-12 | 개시 | Jefferies | Buy |
| 2020-10-12 | 개시 | Piper Sandler | Overweight |
| 2020-10-12 | 개시 | Stifel | Buy |
모두보기
다인 테라 주식(DYN)의 최신 뉴스
DYN Initiated Coverage On by Cantor Fitzgerald -- Rating Set to Overweight - GuruFocus
Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway - The Globe and Mail
Dyne Therapeutics closes $431.4 million stock offering - Investing.com
Dyne Therapeutics closes $431.4 million stock offering By Investing.com - Investing.com Canada
Dyne Therapeutics Announces Closing of Upsized Public - GlobeNewswire
Dyne a new overweight at Cantor on platform for neuromuscular disorders - Seeking Alpha
Cantor Fitzgerald initiates Dyne Therapeutics stock with overweight rating By Investing.com - Investing.com Canada
Dyne Therapeutics (DYN) Prices Upsized Share Offering, Is The Valuation Still Compelling? - Yahoo Finance
Form 424B5 Dyne Therapeutics Inc For: 22 July By Investing.com - Investing.com South Africa
Dyne Therapeutics Launches 18.3M-Share Offering at $20.50; Nets ~$352M, Greenshoe to $405M - TradingView
Analysts Are Bullish on These Healthcare Stocks: Dyne Therapeutics (DYN), ACADIA Pharmaceuticals (ACAD) - The Globe and Mail
Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN) - MSN
Why Dyne Therapeutics (DYN) Stock Is Down Today - Moomoo
Dyne Therapeutics (DYN) Upsizes Public Offering to $375.15M Amid Stock Decline - GuruFocus
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat? - The Globe and Mail
Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower - Benzinga
symbol__ Stock Quote Price and Forecast - CNN
Why is Dyne Therapeutics stock sliding today? By Investing.com - Investing.com Canada
Dyne Therapeutics stock falls 9% after pricing stock offering By Investing.com - Investing.com Australia
Dyne Therapeutics stock falls 9% after pricing stock offering - Investing.com UK
Dyne Therapeutics Prices Upsized $375.2 Million Secondary Offering - marketscreener.com
Form 424B5 Dyne Therapeutics Inc For: 21 July By Investing.com - Investing.com South Africa
Dyne Therapeutics Stock Tumbles After Hours: Here's Why - Benzinga
Form 424B5 Dyne Therapeutics Inc For: 21 July - Investing.com India
DYN: Increased Offering Size and Pricing Range Announced - GuruFocus
Dyne Therapeutics prices $375 million stock offering - Investing.com
Dyne Therapeutics prices $375 million stock offering By Investing.com - Investing.com South Africa
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock - The Manila Times
Dyne Therapeutics prices $375M upsized public o... - Pluang
Dyne Therapeutics,Announces Pricing Of Upsized Offering Of 18.3 Million Shares At $20.50 Per Share - TradingView
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock - GlobeNewswire Inc.
Why DYN Shares Are Down 10% After-Hours? Day After An FDA Win, Another Announcement Rocks Stock - Stocktwits
Stocks to Watch: Super Micro Computer, AAR, Pegasystems, Dyne Therapeutics, Weatherford - Moomoo
Shares of Dyne Therapeutics Slide on $300M Stock Offering - Moomoo
Dyne Therapeutics Launches $300 Million Common Stock Offering - Moomoo
Dyne Therapeutics launches $300 million stock offering By Investing.com - Investing.com Nigeria
Dyne Therapeutics launches $300 million stock offering - Investing.com India
Dyne Therapeutics stock falls on $300M equity offering - Investing.com
Dyne Therapeutics Announces Proposed Public Offering of Common Stock - The Manila Times
Dyne Therapeutics stock falls on $300M equity offering By Investing.com - Investing.com Nigeria
Dyne Therapeutics Announces $300 Million Proposed Public Offering of Common Stock - Quiver Quantitative
Dyne Therapeutics Announces Proposed Public Offering Of Common Stock - TradingView
Press Release: Dyne Therapeutics Announces Proposed Public Offering of Common Stock - Moomoo
다인 테라 (DYN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
다인 테라 주식 (DYN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P | Director |
Jul 07 '26 |
Sale |
23.26 |
297,211 |
6,913,822 |
2,962 |
0.31%
0.83%
자본화:
|
볼륨(24시간):